OncoResponse: Developer of therapeutic antibodies designed to provide care against immuno-oncology targets. The company's technology leverages the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer, providing a larger number of cancer patients with the benefit of immunotherapy.
Sector/industry:
Healthcare
Characteristics:
Based in...
US - Pacific
Clinical Stage
Marketed, Phase III, Phase l or ll
Disease Space
Oncology
Listing
Private
Therapeutic Modalities
Cell Therapy
Website:
Address:
1124 Columbia Street
Suite 300
Seattle, WA 98104
United States

Company Participants at Private Company Showcase NYC Fall 2020

  • Clifford J. Stocks, Co-Founder, Chief Executive Officer & Board Member

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Private Company Showcase NYC Fall 2020

VIRTUAL, October 15, 2020